Fig. 3: Impact of disease stage on overall survival (OS).

Advanced disease stage (defined as other than CP1) at start of 2GTKI treatment (a) and at time of allo-HCT (b) had a negative impact on OS.

Advanced disease stage (defined as other than CP1) at start of 2GTKI treatment (a) and at time of allo-HCT (b) had a negative impact on OS.